Ibuprofen Prices Trend and Forecast

North America

Ibuprofen displayed strong market dynamics with minimal fluctuation in the first quarter of 2023. With the start of Q1 2023, prices increased through the end of February, supported by sustained purchases from the pharmaceutical end-user industry and merchant stocks to meet demand. Also, the ease of trade disruption supported the Ibuprofen market trend from January. With an average quarterly inclination of 1.32%, the settlement prices of Ibuprofen API was recorded at USD 14580/MT CFR in New York. The energy cost was also 19.1% higher in February than a year earlier. Also, better trade flow and simpler logistic charges compared to the prior quarter influenced the market situation positively. On the other hand, the prices dropped in the month of March, backed by enough inventories and low offtakes from the end-user sector.

Asia

Ibuprofen prices witnessed an increasing trajectory in the APAC region in the first quarter of 2023. After the Lunar New Year break, the Chinese pharmaceutical markets technically returned on a positive note with an increase in orders and shipments from both the domestic and the international market. After a week-long Lunar New Year break, Asian currencies, particularly the Chinese Yuan (RMB), rose in the month of January as Chinese markets resumed trade. As the market was reopened, factory and port operations resumed. Also, with the soaring offtake and increase in the no. of international orders, Ibuprofen prices increased in the Chinese market. At the termination of Q1 202, the settlement price of Ibuprofen API accessed at USD 14550/MT EXW Hebei with an average quarterly inclination of 1.56%.

Nonetheless, the prices stabilized at the termination of Q1 2023, as the strict Covid laws lifted, revitalizing the second-largest economy in the world. Also, the recovery of production quickened, along with the rising demand, and kept the market stable. Moreover, supply-chain conflicts greatly decreased, which improved trade with foreign nations. 

Europe

In the first quarter of 2023, Ibuprofen showcased stable market dynamics with slight fluctuation. With the commencement of Q1 2023, the prices rose till the end of February, backed by consistent offtakes from the pharmaceutical end-user sector and inventories among the merchants to cater to the demand. Further, the ease in trade disruption reinforced January’s market trend of Ibuprofen. Also, the Euro currency apprenticed against the USD in the month of January, influencing the market sentiments. During the month of March, the settlement price of Ibuprofen API came down to USD 14880/MT CFR Hamburg with an average quarterly inclination of 0.42%. Moreover, by the termination of Q1 2023, the prices dropped by 1% as the inquiries remained feeble and the merchants had enough supplies.

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.

Comments

Popular posts from this blog

Steel Plate Prices in the Global Market

Levofloxacin Hemihydrate Prices Trend and Forecast

Global Aluminium Sheet Prices Online